Literature DB >> 9658093

Human T-cell leukemia virus type 1 reverse transcriptase (RT) originates from the pro and pol open reading frames and requires the presence of RT-RNase H (RH) and RT-RH-integrase proteins for its activity.

B Trentin1, N Rebeyrotte, R Z Mamoun.   

Abstract

The first description of an active form of a recombinant human T-cell leukemia virus type 1 (HTLV-1) reverse transcriptase (RT) and subsequent predictions of its amino acid sequence and quaternary structure are reported here. By using amino acid alignment methods, the NH2 and COOH termini of the RT, RNase H (RH), and integrase (IN) domains of the Pol polyprotein were determined. The HTLV-1 RT seems to be unique since its NH2 terminus is probably encoded by the pro open reading frame (ORF) fused downstream, via a transframe peptide, to the polypeptide encoded by the pol ORF. The HTLV-1 Pol amino acid sequence was revealed to be highly similar to that of Rous sarcoma virus (RSV), particularly at the RT-RH hinge region. These two domains remain linked for RSV; this may also be the case for HTLV-1. In light of these results, RT, RT-RH, and RT-RH-IN genes were constructed and introduced into His-tagged protein expression vectors. The corresponding proteins were synthesized in vitro, and the DNA polymerase activities of different protein combinations were tested. Solely the RT-RH-RT-RH-IN combination was found to have a significant activity level. Velocity sedimentation analysis suggested that the HTLV-1 RT-RH and RT-RH-IN monomers are likely associated in an oligomeric structure, probably of the alpha3/beta type.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658093      PMCID: PMC109816     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

2.  Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.

Authors:  B J Poiesz; F W Ruscetti; M S Reitz; V S Kalyanaraman; R C Gallo
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

3.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

4.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

5.  Establishing homologies in protein sequences.

Authors:  M O Dayhoff; W C Barker; L T Hunt
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Endonuclease activity of purified RNA-directed DNA polymerase from avian myeloblastosis virus.

Authors:  M Golomb; D P Grandgenett
Journal:  J Biol Chem       Date:  1979-03-10       Impact factor: 5.157

8.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  11 in total

Review 1.  The diversity of retrotransposons and the properties of their reverse transcriptases.

Authors:  Thomas H Eickbush; Varuni K Jamburuthugoda
Journal:  Virus Res       Date:  2008-02-07       Impact factor: 3.303

2.  A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76(gag-pro) defines the N terminus of RT.

Authors:  Gisela Heidecker; Shawn Hill; Patricia A Lloyd; David Derse
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Cooperation between reverse transcriptase and integrase during reverse transcription and formation of the preintegrative complex of Ty1.

Authors:  Marcelle Wilhelm; F-X Wilhelm
Journal:  Eukaryot Cell       Date:  2006-10

4.  Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities.

Authors:  M Wilhelm; M Boutabout; F X Wilhelm
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

5.  Role of integrase in reverse transcription of the Saccharomyces cerevisiae retrotransposon Ty1.

Authors:  M Wilhelm; F-X Wilhelm
Journal:  Eukaryot Cell       Date:  2005-06

Review 6.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

7.  Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.

Authors:  Rashade A H Haynes; Andrew J Phipps; Brenda Yamamoto; Patrick Green; Michael D Lairmore
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

8.  Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.

Authors:  X Wu; H Liu; H Xiao; J A Conway; E Hehl; G V Kalpana; V Prasad; J C Kappes
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase.

Authors:  Kai Zhu; Charles Dobard; Samson A Chow
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins.

Authors:  Eric A Hehl; Pheroze Joshi; Ganjam V Kalpana; Vinayaka R Prasad
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.